Skip to main content
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. logo

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. — Investor Relations & Filings

Ticker · 300760 ISIN · CNE100003G67 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 849 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300760

About Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

https://www.mindray.com

Mindray Bio-Medical Electronics Co., Ltd. is a global developer, manufacturer, and marketer of medical devices and solutions. The company operates through three primary business segments: Patient Monitoring and Life Support, In-Vitro Diagnostics, and Medical Imaging Systems. Its extensive product portfolio includes patient monitors, ventilators, anesthesia machines, ultrasound imaging systems, and automated hematology and chemistry analyzers. The organization focuses on delivering innovative medical technologies designed to enhance clinical efficiency and improve patient outcomes. With a robust research and development infrastructure and a distribution network serving over 190 countries and regions, the company provides integrated solutions to a wide range of healthcare facilities, including primary care clinics and large-scale hospitals. By integrating advanced engineering with clinical insights, the company addresses complex healthcare challenges through reliable and accessible medical equipment.

Recent filings

Filing Released Lang Actions
关于控股股东部分股份质押的公告
Regulatory Filings Classification · 85% confidence The document is a public announcement by Shenzhen Mindray (证券代码300760) disclosing the pledge of shares by its controlling shareholder (Magnifice (HK) Limited). It includes detailed tables of pledged shares, pledge terms, and confirmations that there is no freezing or disposal. This is a routine regulatory disclosure under stock exchange rules and does not correspond to a financial report, management change, capital issuance, share repurchase, voting result, or other specific category. Therefore it falls into the general “Regulatory Filings” fallback category.
2026-05-22 Chinese
2025年度及2026年第一次中期权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is a formal announcement by Shenzhen Mindray Bio-Medical Electronics Co., Ltd. regarding the implementation of the 2025 annual and 2026 first interim profit distribution (dividend) plan. It specifies the cash dividend per 10 shares, record and ex-dividend dates, approval by shareholder meetings, distribution methods, and related details. This clearly matches a Notice of Dividend Amount, not an actual financial report or other category.
2026-05-20 Chinese
关于公司董事会完成换届选举及聘任高级管理人员的公告
Board/Management Information Classification · 99% confidence The document is clearly an official announcement of the completion of the board of directors’ re-election and the appointment of senior management personnel. It provides detailed changes in board composition, committee memberships, and executives’ appointments. This matches the definition of Board/Management Information (code: MANG).
2026-05-19 Chinese
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is an announcement of resolutions passed at the 2025 annual shareholders’ meeting of Shenzhen Mindray Bio-Medical Electronics Co., Ltd., detailing the voting results for each proposal. This is a Declaration of Voting Results at a general meeting, matching the DVA category.
2026-05-19 Chinese
关于选举产生第九届董事会职工代表董事的公告
Board/Management Information Classification · 97% confidence The document is a corporate announcement by Shenzhen Mindray Bio-Medical Electronics Co., Ltd. concerning the election of an employee‐representative director to the ninth board of directors, detailing the candidate’s resume and election process. This is clearly a change/appointment at the board level, fitting the Board/Management Information category (MANG).
2026-05-19 Chinese
关于注销库存股通知债权人的公告
Share Issue/Capital Change Classification · 85% confidence The document is a public announcement by the company regarding the cancellation of treasury shares (剩余库存股) and the corresponding reduction in registered capital, including creditor notification procedures under company law. This is a corporate action affecting the share capital structure rather than a financial report, dividend notice, or insider transaction. Therefore, it falls under the “Share Issue/Capital Change” category.
2026-05-19 Chinese

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.